MedPath
TGA Approval

OPREXA olanzapine 5 mg tablet blister pack (335114)

335114

OPREXA olanzapine 5 mg tablet blister pack

Arrotex Pharmaceuticals Pty Ltd

July 1, 2020

Medicine

Medicine

Active

Registered

Active Ingredients

olanzapine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.